Table 1. Base-line characteristics of the included patients.
| Included patients(n = 77) | |
|---|---|
| Men | 43 (55.8%) |
| Age (years) Median (range) | 57.7 (23–79) |
| >55 | 51 (66.2%) |
| Co-morbidity | 51 (66.2%) |
| Karnofsky performance scale | |
| <70 | 4 (5.1%) |
| 70–80 | 11 (14.1%) |
| >80 | 63 (80.8%) |
| Tumor location | |
| Non-eloquent | 41 (52.6%) |
| Eloquent | 36 (47.4%) |
| Size tumor (cm) | |
| ≤5 | 50 (65%) |
| >5 | 27 (35%) |
| Shinoda score | |
| ≤2 points (stage I) | 46 (60.5%) |
| 3 points (stage II) | 19 (25%) |
| ≥ 4 points (stage III) | 11 (14.5%) |
| Histology | |
| Grade III | 11 (14.3%) |
| -Anaplastic astrocytoma | 6 |
| -Oligodendroglioma | 3 |
| -Oligoastrocytoma | 2 |
| Grade IV | 66 (85.7%) |
| -Glioblastoma multiforme | 65 |
| -Gliosarcoma | 1 |